Dyskinesia News and Research

RSS
Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Research to help patients suffering from severe spinal cord injuries

Research to help patients suffering from severe spinal cord injuries

Study: Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Study: Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Sleep problems in PD patients can worsen in later stages of disease

Sleep problems in PD patients can worsen in later stages of disease

Low accuracy of clinical diagnosis for early Parkinson’s disease

Low accuracy of clinical diagnosis for early Parkinson’s disease

Little efficacy difference between old and new antipsychotics

Little efficacy difference between old and new antipsychotics

Presynaptic dopaminergic lesion predicts drug-induced dyskinesia

Presynaptic dopaminergic lesion predicts drug-induced dyskinesia

Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

New insights into possible common links between neurodegenerative diseases

New insights into possible common links between neurodegenerative diseases

GLNT receives allowance of patent for Parkinson's disease monitoring technology

GLNT receives allowance of patent for Parkinson's disease monitoring technology

Great Lakes NeuroTechnologies receives another patent for Parkinson’s disease monitoring technology

Great Lakes NeuroTechnologies receives another patent for Parkinson’s disease monitoring technology

More antipsychotic medications prescribed to children and adolescents in Germany

More antipsychotic medications prescribed to children and adolescents in Germany

‘Limit diagnostic investigations’ in children with recurrent CAP

‘Limit diagnostic investigations’ in children with recurrent CAP

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Use of radiologic examination of ducts during gallbladder surgery not linked with reduced risk of common duct injury

Use of radiologic examination of ducts during gallbladder surgery not linked with reduced risk of common duct injury

BESTCILIA project aims to improve screening, treatment of Primary Ciliary Dyskinesia

BESTCILIA project aims to improve screening, treatment of Primary Ciliary Dyskinesia

Ecological framework provides better understanding of health-related quality of life in Parkinson's patients

Ecological framework provides better understanding of health-related quality of life in Parkinson's patients

HSG conducts clinical trial with novel drug formulation for treating Huntington disease

HSG conducts clinical trial with novel drug formulation for treating Huntington disease

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study